WebDr. Eric Leire, MD, MBA, Chief Executive Officer: brings to the Company a solid biotechnology expertise through his experience in the pharmaceutical industry (Pfizer, Schering Plough, Pharmacia), biotechnology (CEO of several private and public biotech companies such as APT Therapeutics, Paringenix), academia (Research Associate at … WebContact Email [email protected]. Phone Number +351 239 405 201. BSIM’s mission is to deliver quality drug candidates with high capital efficiency …
BSIM Therapeutics VentureRadar
WebBSIM Therapeutics Contact Us For questions or suggestions, you may contact us below Development Partners Prospective Investors Working With Us Address Instituto Pedro Nunes R. Pedro Nunes Edifício C 3030-199 Coimbra Portugal Phone +351 239 405 201 Email [email protected] WebThe pipeline guide evaluates Amyloidosis (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. pro male wrestlers
Stargardt Disease Research Advances - Foundation Fighting …
WebAffiliations 1 a Instituto Pedro Nunes, BSIM Therapeutics , Coimbra , Portugal.; 2 b Coimbra Chemistry Centre and Chemistry Department, University of Coimbra , Coimbra , Portugal.; 3 c i3S-IBMC - Instituto de Biologia Molecular e Celular Universidade do Porto , Porto , Portugal.; 4 d ICBAS - Institute of Biomedical Sciences Abel Salazar University of … WebAug 18, 2024 · Date of Patent: September 14, 2024 Assignee: BSIM Therapeutics, S.A. Inventors: Rui Manuel Pontes Meireles Ferreira de Brito, Carlos José Vieira Simões, Teresa Margarida Vasconcelos Dias de Pinho e Melo, Bruno Lourenço da Silva Victor, Zaida Catarina Lourenço de Almeida, Ana Lúcia Cabral Cardoso Lopes, Bruno Filipe Oliveira … WebNov 8, 2024 · Exogenus Therapeutics is an early-stage research and development company developing healthcare solutions based on Extracellular Vesicles (EVs) and Exosomes. Founded in 2015, Exogenus is a pioneer in the field of EVs/Exosome-based therapeutics, and a recognized innovator in Umbilical Cord Blood clinical use. kuzuko lodge south africa